A Common Platform for Antibiotic Dereplication and Adjuvant Discovery.

[1]  Andrew C. Pawlowski,et al.  Evolving medicinal chemistry strategies in antibiotic discovery. , 2016, Current opinion in biotechnology.

[2]  E. Brown,et al.  Antibacterial drug discovery in the resistance era , 2016, Nature.

[3]  R. Kishony,et al.  Multidrug evolutionary strategies to reverse antibiotic resistance , 2016, Science.

[4]  John P. Overington,et al.  Comprehensive characterization of the Published Kinase Inhibitor Set , 2016, Nature Biotechnology.

[5]  K. Bush.  A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens. , 2015, International journal of antimicrobial agents.

[6]  Susana P. Gaudêncio,et al.  Dereplication: racing to speed up the natural products discovery process. , 2015, Natural product reports.

[7]  K. Lewis,et al.  A new antibiotic kills pathogens without detectable resistance , 2015, Nature.

[8]  P. Stogios,et al.  Structural and Molecular Basis for Resistance to Aminoglycoside Antibiotics by the Adenylyltransferase ANT(2″)-Ia , 2015, mBio.

[9]  Gerard D. Wright,et al.  Inhibition of the ANT(2")-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic α-hydroxytropolones. , 2014, Bioorganic & medicinal chemistry letters.

[10]  N. Strynadka,et al.  Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance , 2014, Nature.

[11]  Chand S Mangat,et al.  Rank Ordering Plate Data Facilitates Data Visualization and Normalization in High-Throughput Screening , 2014, Journal of biomolecular screening.

[12]  Tatsuya Ito,et al.  Dereplication of microbial extracts and related analytical technologies , 2014, The Journal of Antibiotics.

[13]  T. Willson,et al.  Seeding Collaborations to Advance Kinase Science with the GSK Published Kinase Inhibitor Set (PKIS) , 2014, Current topics in medicinal chemistry.

[14]  H. Goossens,et al.  Antibiotic resistance—the need for global solutions , 2013, BDJ.

[15]  Nicholas Waglechner,et al.  Identifying producers of antibacterial compounds by screening for antibiotic resistance , 2013, Nature Biotechnology.

[16]  R. Edrada-Ebel,et al.  Metabolomics and dereplication strategies in natural products. , 2013, Methods in molecular biology.

[17]  Wei Zhou,et al.  Biosynthesis of albomycin δ(2) provides a template for assembling siderophore and aminoacyl-tRNA synthetase inhibitor conjugates. , 2012, ACS chemical biology.

[18]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[19]  Jens Christian Frisvad,et al.  Dereplication of microbial natural products by LC-DAD-TOFMS. , 2011, Journal of natural products.

[20]  Saurabh Raghuvanshi,et al.  Whole Genome Sequence of the Rifamycin B-Producing Strain Amycolatopsis mediterranei S699 , 2011, Journal of bacteriology.

[21]  Baoli Zhu,et al.  Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism , 2010, Cell Research.

[22]  J. Imhoff,et al.  Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea. , 2010, Journal of natural products.

[23]  R. Bonomo,et al.  Three Decades of β-Lactamase Inhibitors , 2010, Clinical Microbiology Reviews.

[24]  T. Pruett.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America , 2010 .

[25]  M. Ibba,et al.  Characterization of Two Seryl-tRNA Synthetases in Albomycin-Producing Streptomyces sp. Strain ATCC 700974 , 2009, Antimicrobial Agents and Chemotherapy.

[26]  D. J. Russell,et al.  Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis. , 2009, Bioorganic & medicinal chemistry letters.

[27]  J. Bartlett,et al.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  V. Braun,et al.  Sideromycins: tools and antibiotics , 2009, BioMetals.

[29]  Markiyan Samborskyy,et al.  Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338 , 2007, Nature Biotechnology.

[30]  Clay C C Wang,et al.  Total biosynthesis of antitumor nonribosomal peptides in Escherichia coli , 2006, Nature chemical biology.

[31]  V. Braun,et al.  Albomycin Uptake via a Ferric Hydroxamate Transport System of Streptococcus pneumoniae R6 , 2006, Journal of bacteriology.

[32]  H. Mori,et al.  Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection , 2006, Molecular systems biology.

[33]  V. Braun,et al.  Iron hydroxamate transport of Escherichia coli: Nucleotide sequence of the fhuB gene and identification of the protein , 1986, Molecular and General Genetics MGG.

[34]  P. Dawyndt,et al.  BOX-pCR fingerprinting as a powerful tool to reveal synonymous names in the genus Streptomyces. Emended descriptions are proposed for the species Streptomyces cinereorectus, S. fradiae, S. tricolor, S. colombiensis, S. filamentosus, S. vinaceus and S. phaeopurpureus. , 2004, Systematic and applied microbiology.

[35]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Wright,et al.  Resisting resistance: new chemical strategies for battling superbugs. , 2000, Chemistry & biology.

[37]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[38]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[39]  D. Shlaes,et al.  The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  W. Wackernagel,et al.  Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. , 1995, Gene.

[41]  P. Rather,et al.  Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. , 1993, Microbiological reviews.

[42]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[43]  H. Chung,et al.  Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States , 1985, Antimicrobial Agents and Chemotherapy.

[44]  S. Falkow,et al.  Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. , 1977, Gene.

[45]  C Reading,et al.  Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus , 1977, Antimicrobial Agents and Chemotherapy.

[46]  E. Stapley.  Cross-resistance studies and antibiotic identification. , 1958, Applied microbiology.

[47]  E. Stapley,et al.  Similarity of Albomycin and Grisein , 1957, Science.

[48]  Kenneth L. Jones.  FRESH ISOLATES OF ACTINOMYCETES IN WHICH THE PRESENCE OF SPOROGENOUS AERIAL MYCELIA IS A FLUCTUATING CHARACTERISTIC , 1949, Journal of bacteriology.

[49]  S. Waksman,et al.  Grisein, an Antibiotic Produced by Certain Strains of Streptomyces griseus , 1948, Journal of bacteriology.

[50]  W. S. Marsh,et al.  Differentiation of antibiotics by resistant strains. , 1946, Science.

[51]  P. Stansly.  The presumptive identification of antibiotics. , 1946, Science.